Abstract:Abstract Although recent discoveries have linked the tumor suppressing functions of p53 to its regulation on cellular metabolism, the exact signaling pathways underlying how p53 is activated in response to various metabolism stresses, and how p53 coordinates the systemic metabolism homeostasis and further blocks tumorigenesis remain largely unclear. Previous studies have shown that the mice containing a single knock-in at cysteine residue 305 of MDM2 (MDM2C305F) is defective in ribosomal stress (RS) induced p53 activation and display severe nutrient shortage-induced hepatosteatosis. And very recently we found that in response to metabolic stress (MeS), AMPK directly phosphorylates serine 342 of MDMX, leading to p53 activation, which is defective in MDMX3SA mice harboring a mutant MDMX with S341A, S367A and S402A mutations. In the current study, we want to determine if the dual defects in the MDM2/MDMX-p53 pathways might thoroughly impair p53's ability to regulate metabolic homeostasis and thus favor metabolism-related tumorigenesis, by generating a double knock-in (DKI) MDMX3SA/MDM2C305F mouse line. Our results indicate that DKI mice on normal chow diet exhibit mild, but significant, metabolism abnormalities, including increased body weight, higher fasting-glucose level and impaired glucose tolerance, which is exacerbated by high-fat-diet feeding. Consistently, MEFs isolated from DKI mice possess higher capacity of differentiation into adipocytes, and less beige fat is induced in the subcutaneous white adipose tissue of DKI mice after chronic cold exposure. Furthermore, we observe that the survival rate of DKI mice is significantly lower compared to either control or single knock-in groups, which may be due to the higher morbidity of cancers in DKI mice, including hepatoma, lymphoma and lung carcinoma. Because of these observations, we further specifically investigate if dual defects of these p53 activation pathways will accelerate hepatocellular carcinogenesis or not. We indeed find that treatment of carcinogen DEN causes more and bigger tumor nodules in the liver of DKI mice. These results suggest that both RS-MDM2-p53 and MeS-MDMX-p53 pathways play important roles in regulation of global metabolism, and dual defects of these pathways benefit metabolism-related tumor formation and growth. Further study is required to establish the direct effect of the p53 pathway defects-mediated metabolic disruption on tumorigenesis, and determine the underlying mechanisms. Citation Format: Hua Lu, Yi-wei zhang, Peng Liao, Wenjuan Liao, Jiaxiang Chen, Shelya X. Zeng. Dual defects of MDM2/MDMX-p53 pathways cause global metabolic disruption and enhance tumorigenesis. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 891.

The P53 Inhibitors MDM2/MDMX Complex is Required for Control of P53 Activity in Vivo

Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

Inhibition of Nonsense-Mediated Decay Rescues Functional P53β/γ Isoforms in MDM2-amplified Cancers

Secondary Interaction Between MDMX and P53 Core Domain Inhibits P53 DNA Binding.

Mdm2 and Mdmx Prevent ASPP1 and ASPP2 from Stimulating P53 Without Targeting P53 for Degradation.

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

Research progress of regulation mechanism of MDMX and CK1αin p53 tumor suppressor protein

P300/mdm2 Complexes Participate in MDM2-mediated P53 Degradation.

Small Molecule Inhibitors of the P53-Mdm2

Complex Structures of Human MDM2 with Interacting Proteins Reveal the Regulation Mechanism of P53

Modeling the Etiology of p53-mutated Cancer Cells

A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis

XPC promotes MDM2-mediated degradation of the p53 tumor suppressor.

MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells

Critical Role for Daxx in Regulating Mdm2

Interactions Between P53 And Mdm2 In A Mammalian-Cell Cycle Checkpoint Pathway

Induction of P53 Expression and Apoptosis by a Recombinant Dual-Target MDM2/MDMX Inhibitory Protein in Wild-Type P53 Breast Cancer Cells.

Abstract 891: Dual Defects of MDM2/MDMX-p53 Pathways Cause Global Metabolic Disruption and Enhance Tumorigenesis

MDMX Promotes Proteasomal Turnover of P21 at G1 and Early S Phases Independently Of, but in Cooperation With, MDM2.

Nonsense-mediated mRNA decay inhibition synergizes with MDM2 inhibition to suppress TP53 wild-type cancer cells in p53 isoform-dependent manner